Form 4: Therapeutic Solutions International CEO Acquires Shares at Nominal Price

Timothy G. Dixon, President & CEO of Therapeutic Solutions International, acquires 13,333,333 shares of common stock at $0.0006 per share.

Summary

• On July 11, 2024, Timothy G. Dixon, the President & CEO, Director, and a 10% Owner of Therapeutic Solutions International, Inc. (TSOI), acquired 13,333,333 shares of common stock.
• The acquisition price was $0.0006 per share.
• Following the transaction, Dixon beneficially owns 507,683,578 shares of the company's common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment. The filing simply reports a transaction. The low price per share raises some questions, but without further context, it's difficult to assess the overall impact.

Positives

• The CEO's acquisition of a significant number of shares, even at a nominal price, could be interpreted as a sign of confidence in the company's future prospects.

Risks

• The acquisition of shares at a very low price ($0.0006) might raise questions about the valuation of the company's stock and the circumstances surrounding the transaction.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.

Stakeholder Impact

• The transaction could potentially impact shareholder perception of the company, depending on how the market interprets the CEO's acquisition of shares at a nominal price.

Key Dates

Keywords

Therapeutic Solutions International, TSOI, Timothy G. Dixon, stock acquisition, beneficial ownership, Form 4, SEC filing